A human biologics company, Plakous Therapeutics is a patient-focused biotherapeutic company specializing in restorative and regenerative healing. Structured around regenerative therapies R&D, the firm is developing a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. The intent is to improve patient outcomes and reduce health care costs. The firm's first product - designated Protego-PDTM - is an orally delivered acellular biotherapeutic developed from post-delivery placentas
